
Loading, please wait...

Loading, please wait...

The recently launched Lipid Interactome platform offers an open-access portal for investigating the complex relationships between lipids and proteins. Lipid-protein interactions are essential for cellular signaling and maintaining membrane dynamics. However, the biochemical properties of lipids have historically made these interactions difficult to characterize. This new resource provides a centralized database to harmonize and compare diverse proteomics datasets efficiently.
Modern proteomics identification relies on advanced functionalized lipid probes. These probes utilize photoactivatable crosslinkers and affinity handles to identify binding partners with high resolution. Furthermore, the Lipid Interactome platform organizes this data according to FAIR principles, meaning it is Findable, Accessible, Interoperable, and Reusable. Consequently, researchers in India and worldwide can now perform direct cross-study comparisons of bioactive lipids without navigating fragmented repositories.
The database uses standardized formatting and interactive visualizations to simplify complex data. Moreover, it consolidates information from multiple studies, providing a holistic view of the lipid interactome. This consolidation is crucial for deciphering biological functions in health and disease. Therefore, this tool serves as a bridge between basic biochemistry and clinical applications in metabolic and oncological research.
The platform currently hosts curated datasets from various lipid interactome studies. Users can explore specific protein-binding partners through study-specific analysis pages. Additionally, no user registration is required to navigate the portal or download data. This open-access model encourages widespread collaboration and accelerates the validation of candidate lipid-binding proteins.
The platform serves as a centralized, interactive web portal to harmonize and visualize lipid-protein interaction data derived from proteomics studies, making research data more accessible and comparable.
Functionalized lipid probes are synthetic analogs equipped with chemical groups like diazirines for crosslinking and alkynes for enrichment. These tools allow researchers to capture and identify proteins that interact with specific lipids in live cells.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Lipid Interactome is a new open-access web portal designed to harmonize and visualize lipid-protein interaction data for medical researchers....
5 months ago

The Delhi government and DSACS have launched a two-month intensified HIV awareness initiative targeting youth, schools, and local communities. The drive strengthens decentralized testing, expands antiretroviral therapy linkages, ensures legal safeguards under the HIV Act 2017, and provides crucial financial aid.
Today

A multicenter MPOG database study of 289,047 cesarean delivery cases analyzed adherence to obstetric anesthesia best practices. General anesthesia avoidance reached 97.0%, while post-spinal vasopressor infusions (55.4%) and hypothermia prevention (56.7%) showed the lowest compliance, highlighting key targets.
Yesterday

A comprehensive meta-analysis shows digital health technologies significantly improve 6-minute walk distance and peak oxygen uptake in chronic heart failure patients, highlighting the clinical promise of structured remote cardiac rehabilitation.
Today

Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today

A comprehensive analysis of continuous glucose monitoring systems under European Medical Device Regulation 2017/745, examining conformity assessment challenges, Notified Body backlogs, EUDAMED rollout delays, and the critical need for transparent post-market surveillance.
Today